Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Reg. 34 (1) Annual Report

Pursuant to Regulation 34(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby enclosed the 25th Annual Report along with the Notice calling 25th Annual General Meeting of the Company scheduled to be held on Wednesday, 29 September, 2021 at 4:00 p.m. (IST) through Video Conferencing (VC) or Other Audio Visual Means (OAVM) (Comprising of Audited Standalone and Consolidated Financial Statements, Directors Report etc.) which is sent through electronic mode to the Members pursuant to the MCA Circular No. 20/2020 dated 5 May, 2020 read with Circular Nos. 14/2020 dated 8 April, 2020, 17/2020 dated 13 April, 2020 and 02/2021 dated 13 January, 2021 and SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/79 dated 12 May, 2020 and Circular No. SEBI/HO/CFD/CMD2/CIR/P/2021/11 dated 15 January, 2021 for the financial year ended 31 March, 2021
06-09-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Notice Publi

Pursuant to Regulation 47 and Regulation 30 read with Schedule III Part A Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the copies of newspaper advertisement published in English Language Newspaper published in 'Financial Express' and in Vernacular Newspaper in Vernacular Language 'Vadodara Samachar', on 06th September, 2021, in compliance with the Ministry of Corporate Affairs Circular No. 20/2020 dated 5 May 2020, intimating that the 25th Annual General Meeting ('AGM') of members of the Company will be held on Wednesday, 29th September. 2021 at 4:00 p.m. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') and information on related matters as required under the said MCA Circular.
06-09-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

The transcript of the earnings call held on 16 August 2021 post announcement of financial results of the company for the quarter ended 30 June 2021 .
01-09-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing and Obligations and Disclosure Requirements) Regulation 2015, we hereby inform that Mr. Mahesh Tanna, Chief Financial Officer ('CFO') of the Company has tendered his resignation from the post of Chief Financial Officer and Key Managerial Personnel ('KMP') of the Company on 24th August, 2021. The Company has accepted his resignation and he will be relieved from the Company w.e.f 31st August, 2021 after closure of working hours.
24-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Intimation Regarding Continuation Of Registrar And Share Transfer Agent

Pursuant to Regulation 7 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Company has been continuing M/s. Link Intime India Private Limited, as Registrar and Share Transfer Agent (R & T Agent holding a valid Certificate in Category - I with the Securities and Exchange Board of India, vide SEBI Registration No. INR000004058) for the purpose of taking care of all Share registry work of the Company. We ensure that they are maintaining all activities related to share registry in terms of both physical and electronic mode at single point.
18-08-2021

Earnings Call for Q1FY22 of Tatva Chintan Pharma Chem

Conference Call with Tatva Chintan Pharma Chem Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.
17-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations.2015, as amended, we enclosed herewith copies newspaper publication of extract of unaudited financial results of the Company for the quarter ended on 30 June 2021, published in Financial Express (English edition) and Vadodara Samachar (Gujarati edition) on 15 August 2021.
16-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a copy of the Press Release on the financial results of the Company for the quarter ended 30 June 2021.
16-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Intimation under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
14-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Submission Of Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 30Th June, 2021

Submission of Un-audited Standalone and Consolidated Financial Results of the Company for the Quarter ended 30th June, 2021
14-08-2021
Next Page
Close

Let's Open Free Demat Account